Seres Therapeutics, Inc. (Nasdaq: MCRB), a leading microbiome therapeutics company, today reported first quarter 2024 financial results and provided business updates.

Veritone, Inc. (NASDAQ: VERI), a leader in designing human-centered AI solutions, today announced the launch of its AI consulting and services group to bridge the marketplace gap for seamless implementation of AI. With a decade of expertise in developing and deploying AI applications and solutions, Veritone is poised to serve as a strategic partner for AI providers and end customers, facilitating the adoption and integration of AI technologies to drive business success.

The date and time of the Company's previously announced conference call remains unchanged, and will be held on Wednesday, May 8, 2024, at 8:30 a.m. ET. The event will be webcast live and can be accessed at ir.tripadvisor.com. A replay will be available on the website for three months.

ROCKVILLE, Md., May 07, 2024 (GLOBE NEWSWIRE) -- MaxCyte, Inc., (NASDAQ: MXCT; LSE: MXCT), a leading, cell-engineering focused company providing enabling platform technologies to advance the discovery, development, and commercialization of next-generation cell therapeutics and innovative bioprocessing applications, today announced its first quarter ended March 31, 2024 financial results and updated its 2024 guidance. First Quarter Highlights Total revenue of $11.3 million in the first quarter of 2024, an increase of 32% over the first quarter of 2023.Core business revenue of $8.2 million in the first quarter of 2024, an increase of 5% over the first ...